Seminar Weekend

2023 Seminar Weekend – topic

Prescription Drug Prices…Unreasonable but Affordable

Consider this: although 8 in 10 adults say the cost of prescription drugs is unreasonable, only 3 in 10 say they are difficult to afford. This paradox results from complex system of drug pricing and reimbursement in the US, which often shields people from the true cost of the medications they take. This is one of several incentives that make bringing the price of prescription drugs down so difficult.

colorful pills in pillcase

Overview

The 29th Pharmaceutical Outcomes and Policy Seminar will examine the business, economic, and ethical aspects of prescription drug pricing in the context of the complex reimbursement system. Experts will present new policies included in the Inflation Reduction Act and proposed policy solutions, including value-based drug prices and patent reforms. Student and faculty will deliberate the intended and unintended consequences of these policies on patient costs, access, disparity, and innovation – and whether any of these efforts will actually result in lower drug prices.

Logistics

Location: This year’s seminar will take place in-person at the Gainesville campus. See map below for directions.
Dates: March 4-5, 2023

Registration coming soon, please check back.


Speakers

Robin Feldman, JD

Keynore Speaker: "Patent Reforms and Drug Pricing"

Robin Feldman, JD

Arthur J. Goldberg Distinguished Professor of Law, University of California Hastings Law Author of Drugs, Money and Secret Handshakes

Speaker | “Considerations for How Pharmaceutical Companies Set Prices”

Joette Gdovin Bergson, Ph.D., MPA

Partner and Principal, Franklin Pharmaceutical Consulting

Joette Gdovin

SPEAKER | Why Pharmaceutical Markets do not Perform like other economic markets”

Joe Fuhr, Jr., Ph.D.

Professor Emeritus, Widener University
Adjunct Instructional Professor, University of Florida

Joe Fuhr

Speaker | “Medicare Drug Pricing Reforms”

Melissa Andel, MPP

Principal, CommonHealth Solutions
Adjunct Assistant Instructional Professor, University of Florida

Melissa Andel

Speaker | “Implications of Drug Proces and reforms on patients: A Focus on older americans”

Leigh Purvis, MPA

Senior Director, Health Care Costs & Access, AARP Public Policy Institute

Leigh Purvis

SPEAKER | “Value-based Pricing”

James Chambers, Ph.D., M.Pharm.

Associate Professor, Tufts Medical Center

James Chambers

SPEAKER | “Disruption in Prescription Drug Pricing”

Erin Albert, MBA, Pharm.D., JD, DASPL

Vice President, Pharmacy Relations & Chief Privacy Officer, Mark Cuban Cost Plus Drug Co.

Erin Albert